A. Rodríguez

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

D. Amadori, D. Dearnaley, M. Climent, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic counseling in prostate cancer: How to implement it in daily clinical practice?

J. Mateo, Á. Borque-Fernando, E. Castro, 2020, Actas urologicas espanolas.